A review article of pharmacology of long COVID-19 and it's management

A pandemic has recently been declared for COVID-19.Numerous preventive strategies and non-pharmaceutical therapies, including social distance, patient isolation, and strict infection control, have been employed to restrict the spread of disease. With oxygen therapy serving as the primary treatment intervention, management is primarily concerned with providing supportive care. Important management plans have also promoted medical treatment with corticosteroids and antivirals. Nevertheless, there is presently no vaccination for COVID-19 and no particular antiviral medication that is advised for its therapy. Even with the deliberate application of these steps, the rate of newly reported cases is still rising at a very concerning pace. We assess current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available. The number of newly reported cases is still increasing at a very concerning rate in spite of the deliberate application of these procedures. We examine current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-30
DOI
https://doi.org/10.5281/zenodo.17745099
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A review article of pharmacology of long COVID-19 and it's management

Zenodo (CERN European Organization for Nuclear Research)
Long-Term Effects of COVID-19
article

A review article of pharmacology of long COVID-19 and it's management

article en

Abstract

A pandemic has recently been declared for COVID-19.Numerous preventive strategies and non-pharmaceutical therapies, including social distance, patient isolation, and strict infection control, have been employed to restrict the spread of disease. With oxygen therapy serving as the primary treatment intervention, management is primarily concerned with providing supportive care. Important management plans have also promoted medical treatment with corticosteroids and antivirals. Nevertheless, there is presently no vaccination for COVID-19 and no particular antiviral medication that is advised for its therapy. Even with the deliberate application of these steps, the rate of newly reported cases is still rising at a very concerning pace. We assess current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available. The number of newly reported cases is still increasing at a very concerning rate in spite of the deliberate application of these procedures. We examine current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available.

Zenodo (CERN European Organization for Nuclear Research)
Osmania University (IN)
Good health and well-being
Openalex Percentile: Top 35%
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A review article of pharmacology of long COVID-19 and it's management · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS